Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We found that overexpression of endogenous calpain inhibitor calpastatin (CAST) under the control of the calcium/calmodulin-dependent protein kinase II promoter in APP/PS1 mice caused a remarkable decrease of amyloid plaque burdens and prevented Tau phosphorylation and the loss of synapses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP890587.RAi8YrEIo2PRgDUOUQcUVmecusAAKKXW2wuTt-BVuc0L0130_assertion description "[We found that overexpression of endogenous calpain inhibitor calpastatin (CAST) under the control of the calcium/calmodulin-dependent protein kinase II promoter in APP/PS1 mice caused a remarkable decrease of amyloid plaque burdens and prevented Tau phosphorylation and the loss of synapses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890587.RAi8YrEIo2PRgDUOUQcUVmecusAAKKXW2wuTt-BVuc0L0130_provenance.
• NP496099.RAgcWzSHhpWd24SFKwSuea9ME4SROgKtmCHW5mjwZbVHM130_assertion description "[We found that overexpression of endogenous calpain inhibitor calpastatin (CAST) under the control of the calcium/calmodulin-dependent protein kinase II promoter in APP/PS1 mice caused a remarkable decrease of amyloid plaque burdens and prevented Tau phosphorylation and the loss of synapses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP496099.RAgcWzSHhpWd24SFKwSuea9ME4SROgKtmCHW5mjwZbVHM130_provenance.
• NP470055.RA_uMbJxdVJcinx8tuiro-vaC3Qdi0lWUowoEEDA5llpM130_assertion description "[We found that overexpression of endogenous calpain inhibitor calpastatin (CAST) under the control of the calcium/calmodulin-dependent protein kinase II promoter in APP/PS1 mice caused a remarkable decrease of amyloid plaque burdens and prevented Tau phosphorylation and the loss of synapses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP470055.RA_uMbJxdVJcinx8tuiro-vaC3Qdi0lWUowoEEDA5llpM130_provenance.
• NP882035.RAp1gmR1mpUz_WJcwvj95wyXf6ilU1p37v97A0HZywyfY130_assertion description "[We found that overexpression of endogenous calpain inhibitor calpastatin (CAST) under the control of the calcium/calmodulin-dependent protein kinase II promoter in APP/PS1 mice caused a remarkable decrease of amyloid plaque burdens and prevented Tau phosphorylation and the loss of synapses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP882035.RAp1gmR1mpUz_WJcwvj95wyXf6ilU1p37v97A0HZywyfY130_provenance.
• NP659106.RAUYtwyok8tansBjpcoinf40gM8p8AF1fTXCWLCdPKTvY130_assertion description "[We found that overexpression of endogenous calpain inhibitor calpastatin (CAST) under the control of the calcium/calmodulin-dependent protein kinase II promoter in APP/PS1 mice caused a remarkable decrease of amyloid plaque burdens and prevented Tau phosphorylation and the loss of synapses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP659106.RAUYtwyok8tansBjpcoinf40gM8p8AF1fTXCWLCdPKTvY130_provenance.
• NP197936.RA5MVaPnCRXph6KQQ2jkSqJcUatfqJEvhx4EdnNcad5Ik130_assertion description "[We found that overexpression of endogenous calpain inhibitor calpastatin (CAST) under the control of the calcium/calmodulin-dependent protein kinase II promoter in APP/PS1 mice caused a remarkable decrease of amyloid plaque burdens and prevented Tau phosphorylation and the loss of synapses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP197936.RA5MVaPnCRXph6KQQ2jkSqJcUatfqJEvhx4EdnNcad5Ik130_provenance.
• assertion description "[We found that overexpression of endogenous calpain inhibitor calpastatin (CAST) under the control of the calcium/calmodulin-dependent protein kinase II promoter in APP/PS1 mice caused a remarkable decrease of amyloid plaque burdens and prevented Tau phosphorylation and the loss of synapses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We found that overexpression of endogenous calpain inhibitor calpastatin (CAST) under the control of the calcium/calmodulin-dependent protein kinase II promoter in APP/PS1 mice caused a remarkable decrease of amyloid plaque burdens and prevented Tau phosphorylation and the loss of synapses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP280503.RAg7-3LuvnxEum6L0AGuqadfZxPN-oyP7SDTYV58mClqA130_assertion description "[We found that overexpression of endogenous calpain inhibitor calpastatin (CAST) under the control of the calcium/calmodulin-dependent protein kinase II promoter in APP/PS1 mice caused a remarkable decrease of amyloid plaque burdens and prevented Tau phosphorylation and the loss of synapses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP280503.RAg7-3LuvnxEum6L0AGuqadfZxPN-oyP7SDTYV58mClqA130_provenance.
• NP823019.RAe3YePsDIA-gS9r407-W6fwj2wG29DXBH1JeLRbRr6Bw130_assertion description "[We found that overexpression of endogenous calpain inhibitor calpastatin (CAST) under the control of the calcium/calmodulin-dependent protein kinase II promoter in APP/PS1 mice caused a remarkable decrease of amyloid plaque burdens and prevented Tau phosphorylation and the loss of synapses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP823019.RAe3YePsDIA-gS9r407-W6fwj2wG29DXBH1JeLRbRr6Bw130_provenance.
• NP650893.RAhfz3vOaGFgzBgHNQwArF_6DfEtUiyGo8vsUQcdvyMHc130_assertion description "[We found that overexpression of endogenous calpain inhibitor calpastatin (CAST) under the control of the calcium/calmodulin-dependent protein kinase II promoter in APP/PS1 mice caused a remarkable decrease of amyloid plaque burdens and prevented Tau phosphorylation and the loss of synapses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650893.RAhfz3vOaGFgzBgHNQwArF_6DfEtUiyGo8vsUQcdvyMHc130_provenance.
• NP731724.RALFpX4D5RBdsmOGGfPEJL9cPFlPdekgdGJY7zcEfyHts130_assertion description "[We found that overexpression of endogenous calpain inhibitor calpastatin (CAST) under the control of the calcium/calmodulin-dependent protein kinase II promoter in APP/PS1 mice caused a remarkable decrease of amyloid plaque burdens and prevented Tau phosphorylation and the loss of synapses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731724.RALFpX4D5RBdsmOGGfPEJL9cPFlPdekgdGJY7zcEfyHts130_provenance.
• NP773920.RAMENCIs1hYk05OuWxV1vSSiG3rfmp_zL7OStwBOyow4w130_assertion description "[We found that overexpression of endogenous calpain inhibitor calpastatin (CAST) under the control of the calcium/calmodulin-dependent protein kinase II promoter in APP/PS1 mice caused a remarkable decrease of amyloid plaque burdens and prevented Tau phosphorylation and the loss of synapses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773920.RAMENCIs1hYk05OuWxV1vSSiG3rfmp_zL7OStwBOyow4w130_provenance.
• NP823015.RAD2AX2VC_ZIhjmPuh_wAEht0xiFk3LMLvReRbus2rPzk130_assertion description "[We found that overexpression of endogenous calpain inhibitor calpastatin (CAST) under the control of the calcium/calmodulin-dependent protein kinase II promoter in APP/PS1 mice caused a remarkable decrease of amyloid plaque burdens and prevented Tau phosphorylation and the loss of synapses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP823015.RAD2AX2VC_ZIhjmPuh_wAEht0xiFk3LMLvReRbus2rPzk130_provenance.
• NP823013.RApXkKK8iaF7y2deBy7lQc0x-quDgkTz8V_lc93aPDSLc130_assertion description "[We found that overexpression of endogenous calpain inhibitor calpastatin (CAST) under the control of the calcium/calmodulin-dependent protein kinase II promoter in APP/PS1 mice caused a remarkable decrease of amyloid plaque burdens and prevented Tau phosphorylation and the loss of synapses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP823013.RApXkKK8iaF7y2deBy7lQc0x-quDgkTz8V_lc93aPDSLc130_provenance.
• NP823016.RAqEabeNLBkNNw_xt_Pdatg_iNj9jYgNycE-2AB1SjcsE130_assertion description "[We found that overexpression of endogenous calpain inhibitor calpastatin (CAST) under the control of the calcium/calmodulin-dependent protein kinase II promoter in APP/PS1 mice caused a remarkable decrease of amyloid plaque burdens and prevented Tau phosphorylation and the loss of synapses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP823016.RAqEabeNLBkNNw_xt_Pdatg_iNj9jYgNycE-2AB1SjcsE130_provenance.
• NP280514.RAFDSWrdv_R94vZ6WbclAoiiEuNWKahjV2cfhw_N6u8fI130_assertion description "[We found that overexpression of endogenous calpain inhibitor calpastatin (CAST) under the control of the calcium/calmodulin-dependent protein kinase II promoter in APP/PS1 mice caused a remarkable decrease of amyloid plaque burdens and prevented Tau phosphorylation and the loss of synapses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP280514.RAFDSWrdv_R94vZ6WbclAoiiEuNWKahjV2cfhw_N6u8fI130_provenance.
• NP650756.RA13AKTjtLGMRuzNUxq8UGdSuJPnzERewfe2APZuBsaj8130_assertion description "[We found that overexpression of endogenous calpain inhibitor calpastatin (CAST) under the control of the calcium/calmodulin-dependent protein kinase II promoter in APP/PS1 mice caused a remarkable decrease of amyloid plaque burdens and prevented Tau phosphorylation and the loss of synapses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650756.RA13AKTjtLGMRuzNUxq8UGdSuJPnzERewfe2APZuBsaj8130_provenance.